The Prescription: 1st February 2018 Issue
Editor’s EmulsionPSM INDIA Capsules Drug Laws & Policy Injections Pharma Injections DRUG DOPES National Injections Global Injections PSM Pill DOSE OF THE DAY FAQ Subscriber's Symptom UpComing Events Laughter Dose Blog Addict Contact Us
News Archive

Pooja Khaitan


The next time you buy something, think twice before holding the receipt generated on thermal paper. There is a high chance you may be exposing yourself to an endocrine disrupting chemical — Bisphenol-A (BPA). Read more on this hazardous hormone disrupting chemical that we, unknowingly, push into our system in our daily lives in our PSM India capsule and FAQ section.

There has been lots happening around the efficacy of drugs in our country lately. Be it the drugs body setting up a panel to review safety of FDCs or Health policy aiming at comprehensive healthcare for all; ensuring pharma cos do stability tests for all drugs or re-inspecting their manufacturing plants; corporate hospitals starting to report ADRs or monitoring retail drug supplies to patients; it’s all been covered in this issue of The Prescription. Hope you enjoy reading them as much as we did collating them for you.
Growth in the development of rare disease medicines has helped boost the number of new drugs approved in both the United States and the European Union. US saw a 21-year high of 46 new medicines being approved by the US Food and Drug Administration (FDA) in 2017, more than double the number approved the previous year. In the EU 92 new drugs were approved, up from 81 the year before. Our Global Injections carries more details on this while also including drug alerts and global acts and regulations on medicines.


Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on

The request we made in our 1st January issue of The Prescription of each one touching 5 lives this year, including yourself, with your positive actions remains to be seen. Post your pics on our facebook wall or chirp it on our twitter handle. Go ahead and reach out.

Stay Healthy. Stay Protected.

Pooja Khaitan

The Prescription


“Universal Health Coverage will never be achieved in India till the Government spends Rs 8 lac Crores per year dedicatedly used for a robust healthcare system in India. Patience, Perseverance and Passion is needed by the government to provide effective healthcare to us Indians. It’s time to Walk the Talk.”

Mr. Anil Khaitan
President, PHD Chamber of Commerce and Industry

PSM India Capsules

Over 92% People Don't Trust Healthcare System In India: A Report

Have you ever doubted your doctor’s decision? If so, you are not the only one.This is a warning sign. If there is no trust between patients and physicians the positive outcomes of care are highly questionable. As per the GOQii India Fit 2018 report, 92.3% of citizens do not trust the healthcare system in India, which includes doctors, hospitals, pharma, insurance companies and diagnostic labs.The survey claims to have used inputs from about 2 lakh GoQii product users in the country. As per the survey, 74 per cent people said that they do not trust hospitals, followed by pharma and insurance firms (62.8 per cent), medical clinics (52.6 per cent), 50.6 per cent doctors and diagnostic labs (46.1 per cent).

Read More
Why Your Receipts May Be Toxic

The next time you buy something, think twice before holding the receipt generated on thermal paper. There is a high chance you may be exposing yourself to an endocrine disrupting chemical — Bisphenol-A (BPA). A study conducted by environmental NGO Toxics Link states that thermal paper — which is commonly used in receipts at grocery stores, gas stations and ATMs — has been found with high BPA content across markets in Delhi.

Read More
Drug Laws & Policy Injections
Drugs Body To Set Up Panel To Review Efficacy Of FDCsNew Delhi, 16 Jan 2018: India’s chief advisory body on drugs is set to decide on the fate of more than 300 banned drugs in a meeting later this month following complaints from the drug industry. The Drugs Technical Advisory Board (DTAB) is expected to set up expert committees, which will review the safety, efficacy and therapeutic justification of these drugs—called fixed dose combinations (FDCs)—before recommending any action in its 22 January meeting.Read More
Health Policy Aims At Comprehensive Healthcare For People New Delhi, 22 Jan 2018: Union Health Minister J.P. Nadda said that the National Health Policy 2017 aimed at providing healthcare to all people in a comprehensively integrated manner. He was speaking at a function to dedicate the Karnataka Government Koosamma Shambhu Shetty Memorial Haji Abdulla Mother and Child Hospital held at the District Offices Complex.Read More
Regulator Weighs Inspection Of Drug-Making Facilities In USNew Delhi, 16 January 2018: India's drug regulator is looking to inspect US pharmaceutical facilities making "critical" medicines so that only high quality products are imported from them, three government officials have said. Read More
HP: Law On Generic Medicines LikelyDharamsala, 10 Jan 2018: The new BJP government will consider bringing in a legislation to make doctors in the state to prescribe generic medicines. Minister for Health and Family Welfare Vipin Parmar gave this information while talking to The Tribune today. Read More
TB Patients May Get Free Drugs From Private Pharmacies SoonNew Delhi, 11 Jan 2018: Tuberculosis (TB) patients may get to access free TB drugs from private pharmacies soon, something they get only from government-run centres now. The Drugs Technical Advisory Board (DTAB), India’s highest drug advisory body, will consider relaxing the rules in this respect under the Drugs and Cosmetics Act at its 22 January meeting. Read More
DCGI Directs State Drug Controllers To Ensure Pharma Cos Do Stability Testing For All DrugsMumbai, 22 Jan 2018: In order to ensure that drugs do not lose their potency till the expiry dates printed on the package based on the test results, the Central Drugs Standard Control Organisation (CDSCO) has directed all the state drug controllers to ensure that manufacturers do stability testing on drugs before it is marketed as mandated in the law. Read More
Pharma Injections
Drug Regulator Teaming Up To Re-Inspect Manufacturing Plants Of Pharma Cos In Next Three WeeksNew Delhi, 11 Jan 2018: India’s drug regulator is gearing up to re-inspect manufacturing plants of several pharmaceutical companies across the country to ensure they have taken measures to improve the quality of medicines sold here and exported to other markets.Read More
Top 10 Best-Selling Cancer Drugs, Q1–Q3 201715% Year-Over-Year Growth, with Sales Set to More than Double by 2022- Alex Philippidis
The combined sales of all 10 drugs on GEN’s list from January through September of 2017 was $39.632 billion, up 15.2% from $34.407 billion in Q1–Q3 2016. While cancers are among the deadliest of diseases, only one category ranks within the World Health Organization’s list of Top 10 Causes of Death
Read More
Pharmacy Vital For Hospital, Its Profits Can’t Be Taxed Mumbai, 15 Jan 2018: Running a pharmacy is necessary for a hospital to function, reiterated the income-tax appellate tribunal (ITAT), which adjudicates tax disputes. Thus, the income from the pharmacy cannot be treated as ‘business income’ and taxed in the hands of a charitable hospital. Read More
Around 80 Corporate Hospitals Start Reporting ADRs As Part Of PvPI Mumbai, 12 Jan 2018: Around 80 corporate hospitals have started reporting adverse drug reactions (ADRs) as part of their pharmacovigilance activities mandated by the government to promote monitoring of ADRs effectively by healthcare institutions to Pharmacovigilance Programme of India (PvPI). Read More
Drug Pricing Will Get Stringent, But Will Not Be ‘Unfriendly’ To Pharma Industry: NPPA Chief MUMBAI, 22 JAN 2018: The drug pricing regulator may be “perceived” as being unfriendly to the pharmaceutical industry, but that may not be entirely true, observed Bhupendra Singh, Chairman of the National Pharmaceutical Pricing Authority. Read More
Government To Promote Pharma Industry To Set Up Manufacturing Base In Sick States Mumbai, 23 Jan 2018: Union minister of state for health and family welfare Ashwini Kumar Choubey appealed to the Indian pharma industry leaders to set up units in sick states like Bihar, Jharkhand and Uttar Pradesh to gain more productivity at lesser cost considering the fact that many skilled and unskilled human resource migrate from northern region to manufacturing hubs like Maharshtra, Gujarat and other industrial belts. Read More
Drug Dopes
Updated LIST OF NEW DRUGS APPROVED FROM 01-01-2017 TILL DATE BY NEW DRUGS DIVISION, CDSCO, FDA Bhawan, New Delhi List of New Drug Approved by FDA Read More
NPPA Fixes Retail Prices Of 33 Scheduled FormulationsMumbai, 17 Jan 2018: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of of 33 formulations under Drugs (Prices Control) Order, 2013 in related Notification dated January16, 2018. Read More
WHO Revises Advice On Delamanid Drug Use In MDR-TB PatientsChennai, 16 Jan 2018: Delamanid drug, approved for use in multidrug-resistant tuberculosis (MDR-TB) patients by the World Health Organisation in October 2014, did not show any statistically significant difference in successfully curing the disease or reducing the mortality rates compared with a dummy in a Phase III human clinical trial, WHO’s position statement issued on January 15 says. However, the drug was found to be safe unlike many of the other second-line medicines used for MDR-TB treatment. Read More
Maha FDA Seizes Illegal Medicine Stock From Jogeshwari Hospital Mumbai, 10 Jan 2018: In a raid by the Food and Drug Administration (FDA), illegal stock of medicines were seized from a medical centre in a private hospital – Mothercare Maternity and Surgical Hospital at Jogeshwari West. The FDA seized medicines worth over ₹ 4,11,000 from the hospital. Read More
WHO Prequalifies Breakthrough Vaccine For Typhoid Geneva, 3 Jan 2018: At the end of December 2017, WHO prequalified the first conjugate vaccine for typhoid, Bharat Biotech’s Typbar-TCV®. Typhoid conjugate vaccines (TCVs) are innovative products that have longer-lasting immunity than older vaccines, require fewer doses, and can be given to young children through routine childhood immunization programs. The fact that the vaccine has been prequalified by WHO means that it meets acceptable standards of quality, safety and efficacy. This makes the vaccine eligible for procurement by UN agencies, such as UNICEF, and Gavi, the Vaccine Alliance. Read More
Virar: Woman Booked For Giving Fake Pregnancy Medicines For Conceiving Mumbai, 11 Jan 2018: The Virar cops have booked a lady for giving fake medicines which would help a woman conceive and also for looting them of their cash at regular intervals. She used to target women who couldn't conceive as they were an easy prey. One of the victim after getting her monthly cycles complained to the cops as she also found that there were other ladies also whom she had cheated in a similar manner. Worse one of the victims was admitted to hospital as there was a reaction when she consumed the medicine. She had cheated other youths also in the area promising them government jobs and had charged 25000 to 50000 rupees from them. Read More
DCA Seizes ₹ 18 Lakh Worth Of Drugs GUNTUR, 9 JAN 2018: The Drug Control Administration (DCA) sleuths have seized huge quantities of physician sample drugs being sold in retail market illegally at Tenali in Guntur district. The DCA officials have sent the samples for detailed analysis over the suspicion that whether the drugs are genuine or not. Read More
National Injections
Tata Trusts Launches 'Impact Lab' For Public Health Mumbai, 17 Jan 2018: Tata Trusts today said it has set up an 'Impact Lab' at IIT Delhi in partnership with health innovation player PATH for healthcare solutions in areas such as maternal and child health, nutrition and diagnostics for chronic and infectious diseases, among others. Read More
New System Needed To Up Availability Of Doctors: KovindNew Delhi, 17 Jan 2018: President Ram Nath Kovind on Tuesday called for a new regulatory system to enhance availability of doctors and medical professionals as work load of the existing doctors was incredibly high.Read More
Hospitals Slapped With ₹ 19 Lakh Fine For Medical Negligence HYDERABAD, 11 JAN 2018: An increasing number of hospitals and clinics in the city are offering knee, hip and joint replacement surgeries. However, caution needs to be exercised in choosing the right place to go under the knife. Read More
Gujarat FDCA To Monitor Retail Drug Supplies To Patients Towards Achieving Drug Quality & Patient Safety Mumbai, 12 Jan 2018: As part of its crackdown on spurious drugs through post-marketing surveillance programme, Gujarat Food and Drug Control Administration (FDCA) is planning to glean clinical data on drugs consumed by patients from drug retail chain to assess drug quality in the interest of patient safety. Read More
Workshop Highlights Government Initiatives To Make Healthcare Affordable New Delhi, 20 Jan 2018: A workshop on accessibility, availability and affordability of pharmaceutical products was organised by Drugs Control Department of Delhi government in association with National Pharmaceutical Pricing Authority (NPPA) recently. The event helped the department and other stakeholders understand various provisions of DPCO, 2013 and other issues related to essential drugs. Read More
Fake Drugs A New Challenge For Kashmir Society To Combat Srinagar, 20 Jan 2018: Recently news came to front in which the newborn babies were given expired injections at one of the leading maternity hospitals in Kashmir Lal Ded. Be it the ignoring this fact or racket of fake drugs in Kashmir its people who always suffer. Read More
Global Injections
The US Food And Drug Administration Approved 46 New Medicines In 2017 London, 15 Jan 2018: Growth in the development of rare disease medicines has helped boost the number of new drugs approved in both the United States and the European Union, news agency Reuters has reported. Read More
Another EU Fake Velcade Alert, This Time In Finland Finland, 18 Jan 2018: Finnish medicines regulator Fimea has issued a warning against prescribing Janssen-Cilag’s cancer drug Velcade in hospital pharmacies after discovering counterfeits. Read More

Amantadine Now Available To Treat Parkinson Disease Dyskinesia Maryland, 11 Jan 2018: Adamas announced the availability of Gocovri (amantadine) extended-release capsules for the treatment of dyskinesia in patients with Parkinson disease receiving levodopa-based therapy, with or without concomitant dopaminergic medications.Read More

US FDA Acts To Protect Kids From Serious Risks Of Opioid Ingredients Maryland, 11 Jan 2018: The U.S. Food and Drug Administration announced today that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years old because the serious risks of these medicines outweigh their potential benefits in this population.Read More

No Changes To UK Drug Regulations After Brexit London, 18 Jan 2018: The UK’s drugs regulator has reiterated its promise to minimise disruption caused by a potential hard Brexit, telling pharma companies that there will be no sudden changes to the country's regulatory framework when it leaves the EU in March 2019.Read More


INTERDICT Act Gives CBP $9 Million To Spend On Technology To Detect Fentanyl

January 19, 2018: As reported by the Washington Post and USA Today, the recently signed into law INTERDICT Act, an acronym for International Narcotics Trafficking Emergency Response by Detecting Incoming Contraband with Technology, gives U.S. Customs and Border Patrol (CBP) $9 million to increase staff and purchase equipment to detect fentanyl and other opioids at border crossings and mail facilities.

Read More

Counterfeit Pills Laced With Fentanyl Are Ravaging Communities Across North America

For more than a decade, counterfeit drugs with unreliable ingredients have caused patients suffering by not curing their illnesses. Now, counterfeit drugs with deadly ingredients threaten American lives with just one dose. A closed, secure supply chain is even more imperative when the risk of breakage is death.

Read More

Frequently Asked Questions Q1. What is Endocrine Disruption? How do they affect Us? How can we reduce exposure To Hormone-Disrupting Chemicals?
Answer: What keeps you up at night? Sick kids, restless pets, the latest tragedy on the evening news, politics, wars, earthquakes, hurricanes, fires, money troubles, job stress, and family health and wellbeing? There is no shortage of concerns that make us all toss and turn.
But what keeps the chemical industry up at night? A couple of decades ago a senior Shell executive was asked this very question. The answer? Endocrine disruption. If you can even pronounce “endocrine disruption,” you’re doing well. What is it? Why should we care? And why is it keeping chemical bigshots up at night? Read More>>>


What supplements do scientists use, and why?

Article contributed by our subscriber, Prof.V.K.Shastri, Madhya Pradesh

Supplements are a strange thing. Although they’re a multi-billion industry, producers don’t need to prove that they are effective — only that they are safe. As a result, among the evidence-based products, a lot of snake-oil has also snuck on the shelves. Read More

Upcoming Events
UpComing Events
Click Here For More Events
Laughter Dose
Blog Addicts
Dr. Kaushal Kishore tweets: Kudos to PSM-India for making us very much aware of the consequences of spurious medicines!
Ms. Priya Rai, Academician blogs:Patients need to become aware and fight for their rights in every cases of negligence and misbehavior. PSM India has already shown the path and we should strive to follow it!
Dr. Neha Jaiswal, Physician says: Thanks PSM India for all such recent news articles! The Prescription help us to stay informed and updated.
This Newsletter is brought to you by
© 2011 Partnership for Safe Medicines India
F-9, 2nd floor, Kailash Colony, New Delhi -110048;;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.